200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: A randomised, double-blind, placebo controlled trial

Pain

Volumn 83, Issue 1, 1999, Pages 105-107

  McCleane, Gary ^a  

^a Royal Victoria Hospitals Trust   (United Kingdom)

Author keywords

Anticonvulsants; Lamotrigine; Neuropathic pain

Indexed keywords

LAMOTRIGINE; PLACEBO;

ANALGESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; HUMAN; JOINT MOBILITY; MAJOR CLINICAL STUDY; NAUSEA; NOCICEPTION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; TRIGEMINUS NEURALGIA;

ADULT; ANALGESICS; ANTICONVULSANTS; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; TREATMENT FAILURE; TRIAZINES;

EID: 0032857146     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(99)00095-0     Document Type: Article

References (18)

1. Bergouinan M. Cures heureuses de nevralgies faciales essentielles par le diphenylhydantoinate de soude. Rev Laryngol Otol Rhinol. 63:1942;34-41.
2. Campbell F.G., Graham J.G., Zilkha K.J. Clinical trial of carbazepine (Tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiat. 29:1966;265-267.
3. Canavero S., Bonicalzi V. Lamotrigine control of central pain. Pain. 68:1996;179-181.
4. Canavero S., Bonicalzi V. Lamotrigine control of trigeminal neuralgia: an expanded study. J Neurol. 244:1997;527.
5. Canavero S., Bonicalzi V., Ferroli P., Zeme S., Montalenti E., Benna P. Lamotrigine control of idiopathic trigeminal neuralgia. J Neurol Neurosurg Psychiatry. 59:1995;646.
6. Cohen A.F., Ashby L., Crowley D., Land G., Peck A.W., Miller A.A., Lamotrigine. (BW430C), a potential anticonvulsant, Effects on the central nervous system in comparison with phenytoin and diazepam. Br J Clin Pharmacol. 20:1985;619-629.
7. Cohen A.F., Hamilton M.J., Peck A.W., Yuen W.C. Lamotrigine and carbamazepine: a comparison on psychomotor performance. Br J Clin Pharmacol. 89:1986;704.
8. Kingery W.S. A critical review of controlled clinical trials for peripheral neuropathic pain and complex regional pain syndromes. Pain. 73:1997;123-139.
9. Lees G., Leach M.J. Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neuroglial cultures from rat cortex. Brain Res. 612:1993;190-199.
10. Lunardi G., Leandri M., Albano C., Cultrera S., Fracassi M., Rubino V., Favale E. Clinical effectiveness of lamotrigine and plasma levels in essential and symptomatic trigeminal neuralgia. Neurology. 48:1997;1714-1717.
11. McCleane G.J. A prospective audit of the use of lamotrigine in 300 chronic pain patients. The Pain Clinic. 1998;103-108.
12. McCleane G.J. Lamotrigine can remove the pain associated with painful diabetic neuropathy. The Pain Clinic. 11:1998;69-70.
13. McQuay H., Carroll D., Jadad A.R., Wiffen P., Moore A. Anticonvulsant drugs for management of pain: a systematic review. Br Med J. 311:1995;1047-1052.
14. Peck A.W. Clinical Pharmacology of Lamotrigine. Epilepsia. 32:1991;S9-S12.
15. Rull J., Quibrera R., Gonzalez-Millan H., Lozano Castenada O. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine: double-blind crossover study. Diabetologia. 5:1969;215-220.
16. Sterker M., Berrouschot J., Schneider D. Fatal course of toxic epidermal necrolysis under treatment with lamotrigine. Int. J Clin Pharmacol Ther. 33:1995;595-597.
17. Teoh H., Fowler U., Bowery N.G. Effect of Lamotrigine on the electrically-evoked release of endogenous amino acids from slices of dorsal horn of the rat spinal cord. Neuropharmacology. 34:1995;1273-1278.
18. Zakrzewska J.M., Chaudhry Z., Nurmikko T.J., Patton D.W., Mullens E.L. Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain. 73:1997;223-230.